All Stories

CRISPR Therapy and Genetic Disorders

CRISPR Therapy and Genetic Disorders

Recent studies and clinical trials show that NTLA-2001 successfully reduced TTR proteins, considered responsible for ATTR (transthyretin amyloidosis). The NTLA-2001 was used in a clinical study, and this gene-editing technology proved to be a success. Intellia Therapeutics and Regeneron Pharmaceuticals’ conducted…
What We Know About the COVID-19 Delta Variant

What We Know About the COVID-19 Delta Variant

The Delta variant of the novel coronavirus was first discovered in India in December of last year. It rapidly began ravaging the country and then reached Great Britain. It is currently the dominant strain in the United States, as over…